Antidepressants largely ineffective for back pain and osteoarthritis
People need help to live better with their pain, without prescription drugs
2021-01-21
(Press-News.org) Antidepressant drugs are largely ineffective for back and osteoarthritis pain, despite being widely used for these conditions, suggests a review of the evidence published by The BMJ today.
The findings, based on moderate certainty evidence, show that for people with back pain the effects were too small to be worthwhile, but for osteoarthritis a small beneficial effect cannot be ruled out.
Most clinical practice guidelines recommend antidepressants for long term (chronic) back pain and hip and knee osteoarthritis, yet evidence supporting their use is uncertain.
To address this knowledge gap, researchers led by Giovanni Ferreira at the University of Sydney set out to investigate the effectiveness and safety of antidepressants for back and osteoarthritis pain compared with placebo.
Their findings are based on analysis of published data from 33 randomised controlled trials involving more than 5,000 adults with low back or neck pain, sciatica, or hip or knee osteoarthritis.
The trials were designed differently, and were of varying quality, but the researchers were able to allow for this in their analysis. Most of the data came from industry sponsored trials.
The researchers set a difference of 10 points on a 0 to 100 point scale for pain or disability as the smallest worthwhile difference between groups - a threshold commonly used in other studies of chronic pain.
Results showed that serotonin-norepinephrine reuptake inhibitors (SNRIs) reduced back pain after three months. But the effect was small - an average difference of 5.3 points on the pain scale compared with placebo - and unlikely to be considered clinically important by most patients.
For osteoarthritis, they found a slightly stronger effect of SNRIs on pain after three months - an average difference of 9.7 points on the pain scale compared with placebo - meaning that a worthwhile effect could not be excluded.
Low certainty evidence showed that tricyclic antidepressants (TCAs) were ineffective for back pain and related disability.
Tricyclic antidepressants and SNRIs might reduce pain in people with sciatica, but the evidence was not certain enough to draw any firm conclusions.
The researchers acknowledge several limitations, including the possibility of missing trials and being unable to explore a dose-response relation for most antidepressants because of the low number of studies spread across six different classes of antidepressants.
Nevertheless, the review was based on a thorough literature search with a prespecified threshold for clinical importance used in other reviews of treatments for back and osteoarthritis pain.
As such, they say their review updates the evidence for back pain, sciatica, and osteoarthritis, and could help clinicians and their patients decide whether to take antidepressants for chronic pain.
But they conclude: "Large, definitive randomised trials that are free of industry ties are urgently needed to resolve uncertainties about the efficacy of antidepressants for sciatica and osteoarthritis highlighted by this review."
In a linked editorial, researchers at the University of Warwick call for clearer guidance to inform a consistent approach to use of antidepressants for people with painful disorders.
They acknowledge that some patients might choose to try antidepressants for a small chance of a worthwhile reduction in pain after three months.
Overall, however, they argue that drug treatments "are largely ineffective for back pain and osteoarthritis and have the potential for serious harm. We need to work harder to help people with these disorders to live better with their pain without recourse to the prescription pad."
INFORMATION:
Peer reviewed? Yes (research); No (linked editorial)
Evidence type: Systematic review and meta-analysis, Opinion
Subjects: People
ELSE PRESS RELEASES FROM THIS DATE:
2021-01-21
Adding the arthritis drug tocilizumab to standard care for patients in hospital with severe or critical covid-19 is no better than standard care alone in improving clinical outcomes at 15 days, finds a new trial published by The BMJ today.
There was an increased number of deaths at 15 days in patients receiving tocilizumab, resulting in the trial being stopped early.
Today's results contradict earlier observational studies suggesting a benefit of tocilizumab. However, observational effects are limited by a high risk that they may be due to other unknown (confounding) factors - and some studies have not yet been peer ...
2021-01-20
MINNEAPOLIS - A new study has found a brain pressure disorder called idiopathic intracranial hypertension is on the rise, and the increase corresponds with rising obesity rates. The study is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that for women, socioeconomic factors like income, education and housing may play a role in their risk.
Idiopathic intracranial hypertension is when the pressure in the fluid surrounding the brain rises. It can mimic the symptoms of a ...
2021-01-20
MINNEAPOLIS - A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment. The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after treatment. Additionally, more than half of the people with the secondary progressive form of MS experienced no worsening of their symptoms 10 years after a transplant.
While most people with MS are first diagnosed with relapsing-remitting MS, marked by symptom ...
2021-01-20
The new tech elite share distinct views setting them apart from other segments of the world's elite more generally, according to a study published January 20, 2020 in the open-access journal PLOS ONE by Hilke Brockmann from Jacobs University Bremen, Germany, and colleagues.
The global economic landscape over the last half-century is marked by a shift to a high-tech economy, dominated by the "Big Nine" (Amazon, Apple, Facebook, Google, IBM, Microsoft, Alibaba, Baidu, Huawei, and Tencent), computer hardware and software manufacturers, and most recently, app companies. In this study, Brockmann and colleagues investigate the worldviews of the 100 richest people in the tech world (as defined by Forbes).
Though the authors initially approached all 100 of their subjects for a face-to-face ...
2021-01-20
In the Early Bronze Age of Europe, ancient people used bronze objects as an early form of money, even going so far as to standardize the shape and weight of their currency, according to a study published January 20, 2020 in the open-access journal PLOS ONE by Maikel H. G. Kuijpers and C?t?lin N. Popa of Leiden University, Netherlands.
Money is an important feature of modern human society. One key feature of money is standardization, but this can be difficult to identify in the archaeological record since ancient people had inexact forms of measurement compared with today. In this study, the authors assessed possible money from the Early Bronze Age of Central Europe, comparing the objects based on their perceived - if not ...
2021-01-20
The onset date of the yearly rainy season reliably predicts if seasonal drought will occur in parts of Sub-Saharan Africa that are particularly vulnerable to food insecurity, and could help to mitigate its effects. Shraddhanand Shukla and colleagues at the University of California, Santa Barbara's Climate Hazards Center, present these findings in the open-access journal PLOS ONE on January 20, 2021.
Climate-driven seasonal drought can impact crop yields and is among major contributors to food insecurity, which can threaten people's lives and livelihoods. In the last ...
2021-01-20
There may be over 34,000 street cattle in the Indian city of Raipur (one for every 54 human residents), with implications for road accidents and human-cattle conflict.
INFORMATION:
Article Title: A population estimation study reveals a staggeringly high number of cattle on the streets of urban Raipur in India
Funding: The author(s) did not receive any specific funding for this work. However, this work is a part of the Doctor of Philosophy thesis of one of the authors, BKS, who is getting a Junior Research Fellowship under the scheme CSIR-UGC NET for JRF [Sr. No. 2121530765. ...
2021-01-20
Fixed dose combinations of antibiotics are consumed in huge quantities globally, but 80 percent of combinations are not on the WHO Essential Medicines List, and 92 percent are not FDA-approved, - with inappropriate combinations risking inefficacy, toxicity, and selection for antimicrobial resistance
INFORMATION:
Article Title: High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries
Funding: We received no specific funding for this work.
Competing Interests: The authors have declared that no competing interests exist.
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241899
...
2021-01-20
Daddies' girls? Female Bengalese finches prefer their father's song to that of other birds throughout their lives - while sons lose this preference as they grow up.
INFORMATION:
Article Title: Sex differences in the development and expression of a preference for familiar vocal signals in songbirds
Funding: This work was supported by MEXT/JSPS KAKENHI Grant, Numbers 17H06380 to KO & 17J07023 to TGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (https://www.jsps.go.jp/index.html)
Competing Interests: The authors have declared ...
2021-01-20
Boston, Mass. -- Renal cell carcinoma (RCC) is the most common form of cancer of the kidney. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney cancer worldwide. Currently, the 5-year survival rate for patients with metastatic RCC is only about 12 percent. Current treatments include inhibitors of the VEGF and PD-1 pathways. However, resistance to therapy occurs in most patients and new combination treatments are still needed to enhance the efficacy of these current approaches.
Now, investigators have demonstrated that ACE2 expression is a good prognostic factor in RCC, that loss ...
LAST 30 PRESS RELEASES:
[Press-News.org] Antidepressants largely ineffective for back pain and osteoarthritis
People need help to live better with their pain, without prescription drugs
